Literature DB >> 23746756

Antinociceptive effects of oxymatrine from Sophora flavescens, through regulation of NR2B-containing NMDA receptor-ERK/CREB signaling in a mice model of neuropathic pain.

Haiyan Wang1, Yuxiang Li, Linglu Dun, Yaqiong Xu, Shaojv Jin, Juan Du, Lin Ma, Juan Li, Ru Zhou, Xiaoliang He, Tao Sun, Jianqiang Yu.   

Abstract

PURPOSE: In this study we investigated antinociceptive effects of oxymatrine through regulation of NR2B-containing NMDA receptor-ERK/CREB signaling in a chronic neuropathic pain model induced by chronic constrictive injury (CCI) of the sciatic nerve.
METHODS: The von Frey and plantar tests were performed to assess the degree of mechanical and thermal changes respectively. Immunohistochemistry assay was used to evaluate the expressions of NR2B. Western blotting assay were used to evaluate the expressions of NR2B, tERK, p-ERK, tCREB and p-CREB.
RESULTS: The intraperitoneal administration of OMT (160, 80 mg/kg) could prevent the development of mechanical allodynia, thermal hyperalgesia induced by CCI. Intraperitoneal administration of OMT decreased the mean IOD of NR2B in the dorsal horn and expression of NR2B, p-ERK and p-CREB protein.
CONCLUSION: Regulation of NMDA NR2B receptor-ERK/CREB signaling maybe the targets for the antinociceptive effects of OMT on a chronic neuropathic pain model induced by chronic constrictive injury of the sciatic nerve.
Copyright © 2013 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Chronic constrictive injury; NR2B; Neuropathic pain; Oxymatrine from Sophora flavescens; p-CREB; p-ERK

Mesh:

Substances:

Year:  2013        PMID: 23746756     DOI: 10.1016/j.phymed.2013.04.012

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  6 in total

Review 1.  A systematic review and meta-analysis on the use of traditional Chinese medicine compound kushen injection for bone cancer pain.

Authors:  Bao Yanju; Liping Yang; Baojin Hua; Wei Hou; Zhan Shi; Weidong Li; Conghuang Li; Cihui Chen; Rui Liu; Yinggang Qin; Wenliang Lv
Journal:  Support Care Cancer       Date:  2013-11-26       Impact factor: 3.603

Review 2.  Analgesic Alkaloids Derived From Traditional Chinese Medicine in Pain Management.

Authors:  Wei Jiang; Mingze Tang; Limin Yang; Xu Zhao; Jun Gao; Yue Jiao; Tao Li; Cai Tie; Tianle Gao; Yanxing Han; Jian-Dong Jiang
Journal:  Front Pharmacol       Date:  2022-05-10       Impact factor: 5.988

3.  Knockdown of PAR2 alleviates cancer-induced bone pain by inhibiting the activation of astrocytes and the ERK pathway.

Authors:  Yiting Tang; Yupeng Chen; Mingzhu Yang; Qiuhui Zheng; Yaoyuan Li; Yanju Bao
Journal:  BMC Musculoskelet Disord       Date:  2022-05-30       Impact factor: 2.562

4.  Enhanced Expression of TREK-1 Is Related with Chronic Constriction Injury of Neuropathic Pain Mouse Model in Dorsal Root Ganglion.

Authors:  Hyo Jo Han; Seung Wook Lee; Gyu-Tae Kim; Eun-Jin Kim; Byeonghun Kwon; Dawon Kang; Hyun Jeong Kim; Kwang-Suk Seo
Journal:  Biomol Ther (Seoul)       Date:  2016-05-01       Impact factor: 4.634

5.  Propofol produces preventive analgesia via GluN2B-containing NMDA Receptor/ERK1/2 Signaling Pathway in a rat model of inflammatory pain.

Authors:  Qiu Qiu; Liting Sun; Xiao-Min Wang; Amy C Y Lo; Kar Lok Wong; Pan Gu; Sau Ching Stanley Wong; Chi Wai Cheung
Journal:  Mol Pain       Date:  2017 Jan-Dec       Impact factor: 3.395

6.  Zerumbone Modulates α2A-Adrenergic, TRPV1, and NMDA NR2B Receptors Plasticity in CCI-Induced Neuropathic Pain In Vivo and LPS-Induced SH-SY5Y Neuroblastoma In Vitro Models.

Authors:  Jasmine Siew Min Chia; Noor Aishah Mohammed Izham; Ahmad Akira Omar Farouk; Mohd Roslan Sulaiman; Sanam Mustafa; Mark R Hutchinson; Enoch Kumar Perimal
Journal:  Front Pharmacol       Date:  2020-03-04       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.